UPTAKE AND METABOLISM OF TRITIATED OESTRADIOL AND OESTRONE BY HUMAN ENDOMETRIAL AND MYOMETRIAL TISSUE IN VITRO

1974 ◽  
Vol 62 (1) ◽  
pp. 109-123 ◽  
Author(s):  
R. G. GABB ◽  
G. M. STONE
Keyword(s):  
Hydroxysteroid Dehydrogenase ◽  
Endometrial Tissue ◽  
Human Uterus ◽  
Secretory Phase ◽  
Proliferative Phase ◽  
Significant Difference ◽  
Degree Of Oxidation ◽  
Tissue Homogenates ◽  
Uptake And Metabolism

SUMMARY Human endometrial and myometrial tissues were incubated in vitro with [3H]oestradiol-17β and [3H]oestrone to study the uptake and interconversion of these two steroids by the tissues. Endometrial tissue displayed a higher capacity for oestrogen interconversion than myometrial tissue and the oxidation of oestradiol-17β to oestrone was favoured, rather than the reverse reaction. A greater degree of oxidation was found in tissue taken from uteri in the secretory phase than in the proliferative phase. A study of the distribution of radiometabolites between 'soluble' and 'particulate' fractions of tissue homogenates showed that a greater proportion of the tissue radioactivity was associated with the 'particulate' fraction in the proliferative phase than in the secretory phase. After incubation of endometrial tissue from the secretory phase with tritiated oestrogens there was evidence of the formation of chloroform-insoluble radiometabolites and some of these were tentatively identified as oestrogen sulphates. In a second experiment, the uptake and metabolism of the same two oestrogens by tissue from leiomyomata uteri (fibroids) and normal myometrial tissue were compared. No significant difference between these tissues was found. The results suggest that the levels of 17β-hydroxysteroid dehydrogenase in the human uterus may be dependent upon the levels of oestrogens in the blood. The lack of a difference in the treatment of oestrogens by fibroid and normal myometrial tissue suggests that these tissues may have a similar mechanism for the uptake and retention of oestrogens.

THE METABOLISM OF PROSTAGLANDIN E2 BY TISSUES FROM THE HUMAN UTERUS AND FOETO-PLACENTAL UNIT

1978 ◽  
Vol 87 (3) ◽  
pp. 632-642 ◽  
Author(s):  
Eve A. Willman ◽  
W. P. Collins
Keyword(s):  
Endometrial Tissue ◽  
Prostaglandin E ◽  
Human Uterus ◽  
Slight Effect ◽  
High Turnover ◽  
Secretory Phase ◽  
Proliferative Phase ◽  
Catabolic Enzymes ◽  
Decidual Tissue

ABSTRACT The biosynthesis and metabolism of prostaglandin E2 was studied in cell-free homogenates of tissues from the uterus and foeto-placental unit using specific in vitro methods. The results show that the synthesis of prostaglandin E2 is greater in endometrial tissue from the secretory phase (53.07 ± 39.05; ng/100 mg wet tissue/h) than from the proliferative phase of the uterine cycle. Furthermore, endometrial tissue forms more of this compound than myometrium (P < 0.005). During early pregnancy, synthesis is decreased (25.10 ± 16.62); at term, myometrium produces more prostaglandin E2 than decidua. During labour, however, decidual tissue accumulates more of this compound (52.73 ± 18.04) than either myometrium (34.71 ± 13.19) or cord (28.63 ± 11.71). The catabolic enzymes are most active in the placenta and chorion, followed by the cord, myometrium, decidua and amnion, but the differences have only a slight effect on the amounts of prostaglandin E2 which remain at the end of the incubation. The results suggest a high turnover of prostaglandin E2 in the decidua, myometrium and cord.

METABOLISM OF OESTRADIOL-17β AND OESTRONE IN THE HUMAN UTERUS

1975 ◽  
Vol 80 (4) ◽  
pp. 719-731 ◽  
Author(s):  
A. R. Krishnan ◽  
B. K. Bajaj ◽  
V. Hingorani ◽  
K. R. Laumas
Keyword(s):  
Metabolic Activity ◽  
Subcellular Fractions ◽  
Human Endometrium ◽  
Physiological Significance ◽  
Pyridine Nucleotides ◽  
Hormone Action ◽  
Human Uterus ◽  
Secretory Phase ◽  
Proliferative Phase ◽  
Metabolic Conversion

ABSTRACT A study of the metabolism of oestradiol in the human endometrium and myometrium of the proliferative and secretory phases of the cycle showed that the conversion of oestradiol to oestrone by endometrium in the proliferative phase was higher than that in the secretory phase. The decreased metabolic activity of the secretory phase endometrium was attributed to the influence of progesterone on the endometrium. The metabolic conversion of oestradiol to oestrone was enhanced when pyridine nucleotides were added to the system. The conversion of oestradiol to oestrone was maximum in the cytoplasmic and nuclear fractions of the endometrium. Furthermore, the conversion of oestradiol was low in all the subcellular fractions of the myometrium as compared with the endometrial subcellular fractions. The presence of co-factors increased the metabolic conversion of oestradiol to oestrone in the subcellular fractions of the endometrium. The presence of 17β-hydroxysteroid oxidoreductase was indicated in all the subcellular fractions. A correlation was found between the amount of oestradiol and oestrone bound to the receptors in the uterus and the rate of metabolism of oestradiol in the uterus. The physiological significance of metabolism of oestradiol and the hormone action are discussed.

232 DIFFERENTIAL EXPRESSION OF UTERINE CALCIUM-RELATED PROTEINS (NCKX3, NCX1, PMCA1, TRPV6, AND CABINDIN-D9k AND -D28k) DURING HUMAN MENSTRUAL CYCLE

2010 ◽  
Vol 22 (1) ◽  
pp. 274
Author(s):  
K. C. Choi ◽  
E. B. Jeung
Keyword(s):  
Menstrual Cycle ◽  
Medical Center ◽  
Expression Patterns ◽  
Embryo Implantation ◽  
Calcium Balance ◽  
Human Uterus ◽  
Secretory Phase ◽  
Total N ◽  
Proliferative Phase ◽  
Related Proteins

The endometrium is hostile to embryo implantation except during the window of receptivity. A change in endometrial gene expression is required for the development of receptivity. The uterine calcium balance is crucial for physiological functioning, including smooth muscle contraction and embryo implantation. The location of cytoplasmic calcium-related proteins (CRP) include the calcium transporters 1 (CaT1), calbindin-D9k/-D28k (CaBP- 9k/28k), plasma membrane Ca2+-ATPase 1b (PMCA1b), sodium/calcium exchangers (NCX1), and potassium-dependent Na+/Ca2+ exchanger (NCKX3). The expressions of these CRP and their potential roles in the uterus of human during the menstrual cycle remain to be clarified. Thus, in this current study, the expression patterns of CRP were examined for their roles in the human uterus during the menstrual cycle. Human endometrial tissues were collected by curettage from women undergoing hysteroscopy for investigation of tubal patency or tubal ligation. Approval was given by the Human Ethics Committee at SCH Medical Center, Bucheon, and signed consent was obtained in every case. Human uterus (total n = 51) were divided into 3 groups: menstrual, proliferative, and secretory phase. Reverse-transcription PCR and Western blot analysis were applied to measure the level of CRP mRNA and protein, respectively. During the menstrual cycle of human, the expression levels of CaT1 mRNA and protein were increased 5-fold at proliferative phase (Days 6 to 13) compared with secretory phase in the endometrium of uterus. The expression of CaBP-28k mRNA and protein was less 2-fold during the proliferative phase (Days 6 to 13) than during the secretory phase (Days 16 to 28). However, the expressions of NCX1, NCKX3, and PMCA1b mRNA and protein were not altered during cycle, whereas the expression of CaBP-9k was not observed in the uterus of human. In addition, spatial expression of CRP was detected by immunohistochemistry Uterine CRP was abundantly localized in the cytoplasm of the luminal and glandular epithelial cells during menstrual cycle. Taken together, these results indicate that uterine CRP is abundantly expressed in the uterus, suggesting that uterine expression of CRP might be involved in reproductive function during the menstrual cycle in human.

IN VITRO STEROID SYNTHESIS BY FOETAL RABBIT ADRENALS

1971 ◽  
Vol 68 (2) ◽  
pp. 209-218 ◽  
Author(s):  
K. Kurachi ◽  
M. Miyazaki ◽  
H. Mori ◽  
K. Matsumoto
Keyword(s):  
Isotope Dilution ◽  
Hydroxysteroid Dehydrogenase ◽  
Late Gestation ◽  
Cortical Tissue ◽  
Steroid Synthesis ◽  
Metabolic Pattern ◽  
Adrenal Tissue ◽  
Tissue Homogenates

ABSTRACT Adrenal tissue homogenates from foetal rabbits in late gestation and their mothers were incubated with [7α-3H] pregnenolone and analyzed for conversion products by reverse isotope dilution procedures. Deoxycorticosterone and corticosterone were synthesized as main products by foetal as well as by adult adrenals. In addition, small amounts of progesterone, 17-hydroxypregnenolone and cortisol were formed by both adrenals. No C19-steroids and 16α-hydroxysteroids could be found. The results indicate a similarity in the qualitative metabolic pattern of pregnenolone by adrenal cortical tissue of late gestation rabbit foetuses to that of adult rabbits. However, the activity of 3β-hydroxysteroid dehydrogenase per gram tissue in the foetal rabbit adrenal was of the order of one tenth that in the adrenals of their mothers. By using [3H] progesterone as substrate, the activities of 21-hydroxylase and 11β-hydroxylase in the foetal adrenal were similarly demonstrated to be less than that of the adrenal of the mother.

IN VITRO METABOLISM OF [6,7-3H]NORETHYNODREL IN THE HUMAN ENDOMETRIUM AND THE MYOMETRIUM

1973 ◽  
Vol 74 (3) ◽  
pp. 576-591 ◽  
Author(s):  
K. Murugesan ◽  
V. Hingorani ◽  
K. R. Laumas
Keyword(s):  
Subcellular Fractions ◽  
Human Endometrium ◽  
In Vitro Metabolism ◽  
Supernatant Fraction ◽  
Chromatographic Mobility ◽  
Secretory Phase ◽  
Proliferative Phase ◽  
Polar Metabolites

ABSTRACT The human endometrium and the myometrium have the capacity to convert [6,7-3H]norethynodrel to norethindrone, 17α-ethynyl-3α,17β-dihydroxy-5-(10)-oestrene and two other unidentified metabolites. Under in vitro conditions, 80–90 % of 3H-norethynodrel was converted to its metabolites within 90 min. The metabolites formed were the same for both the endometrium and the myometrium. The amount of norethynodrel converted to its metabolites was more in the proliferative phase than in the secretory phase. Among the subcellular fractions of the myometrium, mitochondrial and microsomal fractions metabolised norethynodrel to norethindrone and two polar metabolites with low chromatographic mobility. In the myometrial 105 000 × g supernatant fraction, 17α-ethynyl-3α,17β-dihydroxy-5(10)-oestrene was formed in addition to norethindrone and the polar metabolites. The significance of the formation of norethindrone – a potent oral progestin as a product of the metabolism of norethynodrel and its possible action at the uterine level in the control of fertility is discussed.

scholarly journals FKBP4 is regulated by HOXA10 during decidualization and in endometriosis

Reproduction ◽  
2012 ◽  
Vol 143 (4) ◽  
pp. 531-538 ◽  
Author(s):  
Huan Yang ◽  
Yuping Zhou ◽  
Benjiamin Edelshain ◽  
Frederick Schatz ◽  
Charles J Lockwood ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Stromal Cells ◽  
Secretory Phase ◽  
Endometrial Stromal Cells ◽  
Eutopic Endometrium ◽  
Protein Levels ◽  
Proliferative Phase ◽  
Progestin Receptor ◽  
Fertile Women

FKBP4 (FKBP52) and FKBP5 (FKBP51) are progestin receptor (PR) co-chaperone proteins that enhance and inhibit, respectively, progestin-mediated transcription by PR. Here, we examinedFKBP4andFKBP5expression in the eutopic endometrium of fertile women with endometriosis and effects of FKBP4 and FKBP5 on the decidualization of human endometrial stromal cells (HESCs), and assessed HOXA10 regulation of FKBP4. Expression ofFKBP4mRNA was increased in the late proliferative phase and remained elevated throughout the secretory phase.FKBP5expression was low and remained constant throughout the menstrual cycle. Compared with controls,FKBP4mRNA expression was decreased in the endometrium of women with endometriosis, whereas no significant endometriosis-related change was seen forFKBP5. Cultured HESCs were treated with eitherFKBP4orFKBP5siRNA and then decidualized by incubation with progesterone (P4) and 8-bromoadenosine cAMP. Treatment of HESCs withFKBP4siRNA resulted in 60% lowerIGFBP1expression. In contrast, incubation withFKBP5siRNA did not significantly decreaseIGFBP1expression duringin vitrodecidualization.HOXA10andFKBP4expression increased in parallel duringin vitrodecidualization. In HESCs, overexpressed HOXA10 enhanced FKBP4 mRNA and protein levels, whereas HOXA10 knockdown decreased FKBP4 mRNA and protein levels compared with controls. Similarly, duringin vitrodecidualization,FKBP4expression was decreased in HOXA10-silenced cells. EnhancedHOXA10expression in HESCs elicits a decidualization mediating increase inFKBP4expression. The findings are consistent with the observation that women with endometriosis have diminishedFKBP4expression leading to impaired decidualization and infertility. The P4resistance seen in endometriosis may be mediated through HOXA10-regulatedFKBP4expression.

Metabolism and receptor binding of nandrolone and testosterone under in vitro and in vivo conditions

1985 ◽  
Vol 110 (3_Suppla) ◽  
pp. S31-S37 ◽  
Author(s):  
E. W. Bergink ◽  
J. A. A. Geelen ◽  
E. W. Turpijn
Keyword(s):  
Androgen Receptor ◽  
Receptor Binding ◽  
Reductase Activity ◽  
Hydroxysteroid Dehydrogenase ◽  
In Vivo Studies ◽  
Muscular Tissue ◽  
Binding Studies ◽  
Tissue Homogenates

Abstract. The metabolism and receptor binding of nandrolone (N) and testosterone (T) were studied under in vitro and in vivo conditions. The results of both in vitro incubation studes with 3H-N and 3H-T in tissue homogenates from rats and in vivo infusion studies with 3H-N and 3H-T in conscious rats show the importance of the enzymes 5α-reductase and 3α/β-hydroxysteroid-oxidoreductases in the prostate and the importance of the enzyme 17β-hydroxysteroid dehydrogenase in the kidney for the effects of N and T on these tissues. Following infusion of a combined dose of 3H-N and 3H-T there is a preferential retention at the receptor of 5α-dihydrotestosterone (DHT) over 5α-dihydronandrolone (DHN), N and T (DHT ⪢ DHN > N > T) in the prostate because T is a better substrate than N for 5α-reductase and because DHT binds more strongly to the androgen receptor than DHN, N and T. In the kidney 5α-reductase is not important; there is a preferential retention of N in T (DHN and DHT were only present in small amounts) because N is less susceptible than T for metabolic inactivation by the enzyme 17β-hydroxysteroid dehydrogenase and N binds strongly to the androgen receptor. Both in vitro and in vivo studies show that N and T were relatively stable in spleen, thymus and muscular tissue (only shown in vivo) and, as a result, the same amount of N and T was bound to the receptor in these tissues in the in vivo infusion experiment. In vitro binding studies with the androgen receptor in intact human cells show that 5α-reduction increases the affinity of T and decreases the affinity of N and of the 17α-ethyl derivative of N (3-keto-ethylestrenol). The results of the present studies explain the relatively strong effect of N, or derivatives of N, compared to that of T on tissues devoid of 5α-reductase activity (e.g. muscular tissue) and they suggest that in particular there may be a strong effect of N on tissues which in addition have a high 17β-hydroxysteroid dehydrogenase activity (e.g. kidney).

scholarly journals Aberrant Expression of Fgl-1 and Lag-3 in Adenomyosis

2021 ◽  
Author(s):  
Wenjing Sun ◽  
Xiaoyan Qin ◽  
Guangxi Yuan ◽  
Na Li ◽  
Junhui Liang ◽  
...  
Keyword(s):  
Uterine Cavity ◽  
Lymphocyte Activation ◽  
Secretory Phase ◽  
Normal Endometrium ◽  
Aberrant Expression ◽  
Proliferative Phase ◽  
Cell Immunity ◽  
Significant Difference ◽  
Mechanical Factors ◽  
Ectopic Endometrium

Abstract Background: The presence of ectopic functional endometrial glands and stroma in the myometrium of the uterine cavity is considered as adenomyosis. Various inflammatory, vascular and mechanical factors are involved in the symptoms and evolution of this pathology. Lymphocyte-activation gene 3 (Lag-3) is an immune inhibitory receptor and fibrinogen-like protein 1 (Fgl-1) is a major functional ligand of Lag-3. The binding of Lag-3 and Fgl-1 leads to inhibition of T-cell immunity, which is an important target of immunotherapy. The objective of this study was to evaluate the expression of Lag-3 and Fgl-1 in normal endometrium and adenomyosis.Methods: The expression of the Lag-3 and Fgl-1 in normal endometrium (proliferative phase: n=15; secretory phase: n=15) and adenomyotic endometrium (proliferative phase: n=15; secretory phase: n=15) were determined using immunohistochemistry and immunofluorescence analysis.Results: In normal and adnomyotic endometrium, no significant difference of Fgl-1 expression was noted between proliferative and secretory phases. Compared with normal endometrium, eutopic and ectopic endometrium of adenomyosis showed increased expression of Fgl-1. Lag-3 was almost negative in endometrial glands of normal and adenomyosis. Compared with normal endometrium, Lag-3 positive T-lymphocytes were more common in the stroma of adenomyosis.Conclusions: Our data suggest that aberrant expression of Lag-3 and Fgl-1 is present in the eutopic and ectopic endometrium of adenomyosis. We conclude that Lag-3/Fgl-1 signaling may be involved in the pathogenesis and development of adenomyosis.

OESTRADIOL-17β UPTAKE IN VITRO INTO THE NUCLEI OF ENDOMETRIUM FROM DIFFERENT REGIONS OF THE HUMAN UTERUS

1975 ◽  
Vol 78 (2) ◽  
pp. 353-363 ◽  
Author(s):  
C. B. Lunan ◽  
B. Greenz
Keyword(s):  
Regional Differences ◽  
The State ◽  
Nuclear Accumulation ◽  
Lower Body ◽  
Human Uterus ◽  
Secretory Phase ◽  
Body Regions

ABSTRACT Specimens of endometrium from the vault, body and lower body regions of the same human uteri were incubated separately for 30 min in vitro in the presence of 1–6 × 10−9m 3H-oestradiol. Uptake into the nuclei was variable but in general the vault region endometrium was least active in nuclear accumulation of the hormone, especially in secretory phase endometrium. This suggests that intra-uterine variations found in oestradiol uptake in vivo are due to regional differences in the state of the tissue itself.

scholarly journals Motion Appearance of Women in the Menstrual and Endometrial Cycle

2017 ◽  
Vol 3 (2) ◽  
pp. 85
Author(s):  
Santika Rentika Hadi
Keyword(s):  
Menstrual Cycle ◽  
Motor Skills ◽  
Minimum Energy ◽  
Human Motion ◽  
Menstrual Phase ◽  
Secretory Phase ◽  
Fourth Group ◽  
Psychological Conditions ◽  
Proliferative Phase ◽  
Significant Difference

In the endometrium and menstrual cycle, occurs several phase. Those are Menstrual Phase, Proliferative Phase, Secretaory Phase and Phase Ischemi. In the these phase occurs change in outpouring of sex hormones (estrogen and progesterone) that are closely related to the psychological condition (stress and emotions). Psychological conditions in these cycles is estimated to affect the appearance of human motion, appearance of motion in motor skills which means the ability to bring maximum results with spends certain minimum energy and time. The aim of this research was to reveal differences in the appearance of motion in the 200-meter run at the menstrual cycle and endometrium phase. Result of the statistical analysis showed that the appearance of motion in the form of 200-meter run in the fourth group of the menstrual phase, proliferative phase, secretory phase, and ischemic phase has no significant difference (P> 0.05). The conclusion of this research there was no differences in the appearance of motion (travel time to run 200 meters) in a woman in a state of menstrual phase, proliferative phase, secretory phase, and ischemic phase.

Sign in / Sign up

Export Citation Format

Share Document